Outsourcing Considerations For Novel Protein Therapeutics

Описание к видео Outsourcing Considerations For Novel Protein Therapeutics

Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio, Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics, and Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech discuss special considerations for outsourcing the development and manufacturing of novel, complex protein therapeutics in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics.

Check out the full webinar available on-demand - https://www.bioprocessonline.com/doc/...

Комментарии

Информация по комментариям в разработке

Похожие видео